Leadless pacemaker implantation following transvenous lead extraction resulted in no mortality, device reinfections, or long-term complications at a minimum of 12 months follow-up in 10 patients.
Case Report (n=10)
No
Does leadless pacemaker implantation improve safety and reduce infections following transvenous lead extraction?
Leadless pacemakers offer a safe alternative following transvenous lead extraction, potentially reducing subsequent device-related infections.
Key Teaching Points•Leadless pacemaker implantation reduces risks of device-related infections and complications following transvenous lead extraction.•Long-term safety of leadless pacemaker utilization after transvenous lead extraction is demonstrable in this study.•Transvenous lead extraction procedure is associated with significant complications and must be individualized. •Leadless pacemaker implantation reduces risks of device-related infections and complications following transvenous lead extraction.•Long-term safety of leadless pacemaker utilization after transvenous lead extraction is demonstrable in this study.•Transvenous lead extraction procedure is associated with significant complications and must be individualized.
Tay et al. (Tue,) conducted a case report in Cardiovascular implantable electronic device (CIED) infection or lead failure requiring transvenous lead extraction (n=10). Leadless pacemaker (Micra) implantation was evaluated on Mortality, adverse events related to device reinfection, or long-term complications. Leadless pacemaker implantation following transvenous lead extraction resulted in no mortality, device reinfections, or long-term complications at a minimum of 12 months follow-up in 10 patients.